No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
November 17, 2011
Agios Pharmaceuticals raises a $78,000,000 series C round from ARCH Venture Partners, Third Rock Ventures and Celgene.
Funding rounds
Funding round
Funding round amount (USD)
Funding type
Funding round date
Investment
78,000,000
November 17, 2011
ARCH Venture Partners
Celgene
Third Rock VenturesPeople
Name
Role
LinkedIn
Abhishek Jha
Employee
Amit Patel
Investor
Christopher Dovletoglou
Employee
Darrin Miles
Employee
Fay Xing
Investor
Fran Lacombe
Employee
Grant K. Walkup, PhD
Employee
Jay Vaithilingam
Employee
Jenny Che
Employee
Kate McSheffrey
Employee
Laura J. Palermino
Employee
Osman Emara
Employee
Patrizio Renzetti
Employee
Thomas Roddy
Employee
Tien Dao
Employee
Further reading
Title
Author
Link
Type
Date
Auto-extract from URL...
Documentaries, videos and podcasts
Title
Date
Link
Auto-extract from URL...
Companies
Company
CEO
Location
Products/Services
Agios Pharmaceuticals
Is a
CompanyCompany attributes
Pharmaceutical industry
Biotechnology
HealthcareLocation
Cambridge, MassachusettsCIK number
1,439,222
Place of incorporation
DelawareOther attributes
Country
United StatesHeadquarters
Stock symbol
AGIO
Stock exchange
NASDAQMarket
SIC code
2,834
